A15.7 Primary respiratory tuberculosis

Name of the Condition

• Primary respiratory tuberculosis (ICD-10-CM: A15.7)

Summary

Primary respiratory tuberculosis is a contagious bacterial infection affecting the respiratory system, caused by Mycobacterium tuberculosis. It spreads through airborne droplets from an individual with active TB. This condition is part of the broader respiratory TB category and typically involves initial infection in the lungs or associated structures.

Causes

Primary respiratory tuberculosis is caused by the bacterium Mycobacterium tuberculosis. Infection occurs when a person inhales respiratory droplets containing the bacteria, usually from someone with active TB. The bacteria settle in the respiratory tract, leading to infection and potential spread to nearby tissues.

Risk Factors

• Prolonged exposure to someone with active TB.
• Living in or traveling to areas with high TB prevalence.
• Compromised immune system (e.g., HIV/AIDS, diabetes).
• Substance abuse, including alcohol and tobacco.
• Malnutrition or poor living conditions.

Symptoms

• Persistent cough (lasting three weeks or more).
• Hemoptysis (coughing up blood).
• Fever, chills, and night sweats.
• Unintended weight loss.
• Chest pain or discomfort.
• Fatigue and weakness.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. A chest X-ray may show characteristic lung changes, while sputum tests (microscopy, culture, or nucleic acid amplification) confirm the presence of Mycobacterium tuberculosis. Additional tests, such as tuberculin skin tests or interferon-gamma release assays, may assess exposure or infection.

Treatment Options

Treatment typically involves a multi-drug regimen over several months, including isoniazid, rifampin, ethambutol, and pyrazinamide. Directly observed therapy (DOT) is often recommended to ensure adherence. Drug-resistant TB may require alternative medications and longer treatment durations.

Prognosis and Follow-Up

With appropriate treatment, most patients recover fully. Follow-up includes monitoring for treatment response, side effects, and potential relapse. Regular sputum tests and clinical assessments are essential to confirm cure and prevent transmission.

Complications

• Lung damage or scarring.
• Respiratory failure.
• Spread of infection to other organs (extrapulmonary TB).
• Drug-resistant TB.
• Recurrence after treatment completion.

Lifestyle & Prevention

• Avoid close contact with individuals who have active TB.
• Ensure proper ventilation in living or work environments.
• Complete the full course of prescribed treatment if infected.
• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Get tested for TB if at high risk or experiencing symptoms.

When to Seek Professional Help

Seek medical attention if you experience a persistent cough, unexplained weight loss, fever, or other respiratory symptoms, especially if you have been exposed to TB. Prompt evaluation is critical for early diagnosis and treatment.

Tips for Medical Coders

When coding A15.7, ensure documentation specifies "primary" respiratory tuberculosis to distinguish it from other respiratory TB subtypes. Verify that the diagnosis aligns with clinical findings and laboratory results. Document any relevant risk factors or complications to support code specificity.